Literature DB >> 15778594

Forty years of changing indications in penetrating keratoplasty in Israel.

Claudia Yahalom1, Hadas Mechoulam, Abraham Solomon, Frederick D Raiskup, Jacob Peer, Joseph Frucht-Pery.   

Abstract

PURPOSE: To examine the leading indications for keratoplasty and identify the changing trends in the past 40 years in Israel.
METHODS: Pathology reports of all penetrating keratoplasties (PKPs) performed at Hadassah-Hebrew University Hospital from 1961 to 2000 were reviewed. We evaluated the indications for keratoplasty in each decade between the years 1961 and 2000.
RESULTS: During the 40-year period, a total of 1681 PKPs were performed. Keratoconus (n = 478, 28.4%) was the most common indication, followed by graft failure (n = 226, 13.4%), pseudophakic corneal edema (PCE) (n = 142, 8.4%), herpetic infections (n = 125, 7.4%), nonherpetic infections (n = 114, 6.8%), scarring (n = 113, 6.7%), and trauma (n = 110, 6.5%). The 7 groups account for approximately 77.5% of all keratoplasties performed. Ocular infections were the most common indications before 1970 and have been declining ever since. Keratoconus became the leading indication in the past 30 years. In the past decade, of 663 keratoplasties, keratoconus was the most common indication (56, 38.6%) followed by graft failures/rejections and PCE (the second most common indication between the years 1981 and 1990).
CONCLUSIONS: Keratoconus was the leading indication for keratoplasty in our series. There was a decreasing trend in PK for ocular herpetic infections during the decades. The rate of PCE decreased while failed graft became the second most common indication for PKP during the past decade.

Entities:  

Mesh:

Year:  2005        PMID: 15778594     DOI: 10.1097/01.ico.0000148310.63755.74

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  14 in total

1.  A retrospective clinical study of Xinjiang Uygur patients with corneal allograft rejection.

Authors:  Reziwan Maimaitiming; Xin Yang; Kelala Wupuer; Nan Ye; Na Kong; Baoyu Gu; Yuanyuan Fan; Lan Shao; Zhiqiang Pan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Fuchs' corneal dystrophy.

Authors:  Allen O Eghrari; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2010-04

Review 3.  Corneal blindness and xenotransplantation.

Authors:  Vladimir Lamm; Hidetaka Hara; Alex Mammen; Deepinder Dhaliwal; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-02-21       Impact factor: 3.907

4.  Gender differences in keratoconus keratoplasty: a 25-year study in Southern Brazil and global perspective.

Authors:  Otavio A Magalhaes; Samara B Marafon; Raissa C Ferreira
Journal:  Int Ophthalmol       Date:  2017-08-22       Impact factor: 2.031

5.  Trends in the indications for penetrating keratoplasty in Shandong, 2005-2010.

Authors:  Jun-Yi Wang; Li-Xin Xie; Xiu-Sheng Song; Jing Zhao
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

6.  Impact of new lamellar techniques of keratoplasty on eye bank activity.

Authors:  Marc Muraine; David Toubeau; Julie Gueudry; Gerard Brasseur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-10       Impact factor: 3.117

7.  Deep anterior lamellar keratoplasty: indications, surgical techniques and complications.

Authors:  Farid Karimian; Sepehr Feizi
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

Review 8.  Graft failure: III. Glaucoma escalation after penetrating keratoplasty.

Authors:  Emily C Greenlee; Young H Kwon
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

9.  Changing indications for penetrating keratoplasty in Homburg/Saar from 2001 to 2010--histopathology of 1,200 corneal buttons.

Authors:  Jiong Wang; Andrea Hasenfus; Frank Schirra; Rainer M Bohle; Berthold Seitz; Nóra Szentmáry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-01       Impact factor: 3.117

10.  Deep anterior lamellar keratoplasty using the big-bubble technique in keratoconus.

Authors:  Mohammad-Ali Javadi; Sepehr Feizi; Hossein Jamali; Firooz Mirbabaee
Journal:  J Ophthalmic Vis Res       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.